Nasheed Mohammad Hossain, MD
Ann B. Young Assistant Professor in Cancer Research
Member, Abramson Cancer Center
Chair - Transfusion Committee, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
University Of Pennsylvania - Perelman School of Medicine
PCAM South Pavilion, Floor 12
Philadelphia, PA 19104
PCAM South Pavilion, Floor 12
Philadelphia, PA 19104
Education
BA (Genetics and Development )
Cornell University , 2006.
MD (Medicine)
Case Western University Reserve University School of Medicine , 2010.
Permanent linkBA (Genetics and Development )
Cornell University , 2006.
MD (Medicine)
Case Western University Reserve University School of Medicine , 2010.
Description of Clinical Expertise
Stem Cell TransplantLymphoma
Chimeric Antigen Receptor Therapies
Malignant Hematology
Description of Other Expertise
Engagement with minority and underserved communities to enhance engagement with appropriate blood cancer related care (in terms of transplant and cell therapies) and appropriate opportunities to participate in cutting edge clinical studies.Description of Research Expertise
Expertise in Cancer Immunology and T-cell biology with a focus on the development of cellular immunotherapies. Also focusing on diagnosis and treatment of acute and chronic GVHD in allogeneic stem cell transplant patients.Secondary focusing on increasing engagement with minority/historically underrepresented racial/ethnic groups to enhance their representation in early and late-stage clinical trials.
Selected Publications
Schneider M, Paruzzo L, Stella F, Noll JH, Ho M, Babatunde V, Ho B, Devi P, Chong EA, Barta SK, Nasta SD, Svoboda J, Carter J, Cook MR, Hossain NM, Thomas CJ, Patel V, de Souza VB, Alkhatib MH, Li Z, Tan M, Michener P, Guruprasad P, Imparato A, Carturan A, Porazzi P, Fraietta JA, Schuster SJ, Maillard I, Ruella M, Landsburg DJ.: Naïve CD4(+) T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy. Nat Commun May 2026.Baron J, Chelius M, Cohen L, Perez CC, Riina M, Ramesh S, Tierney A, Elghawy O, Hossain NM, Rook A, Villasenor-Park J, Samimi S, Kim E, Hubbeling H, Plastaras JP, Barta SK, LaRiviere M.: Standard Versus Hypofractionated Low-Dose Total Skin Electron Therapy for Cutaneous T-Cell Lymphoma: A Single-Institution Retrospective Analysis. Pract Radiat Oncol Apr 2026.
Wang T, Ferreira AC, Hossain NM, Fu D, Hill EG, Jimenez Jimenez AM, Benjamin C, Komanduri KV, Paczesny S.: Day-30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation. Br J Haematol Apr 2026.
Mirza AS, Hosing C, Foss F, Kim S, Moskop A, Oloyede T, Abid MB, Afrough A, Ahmed S, Badar T, Barba P, Bhatt VR, Brown VI, Dahiya S, Deol A, Epperla N, Ganguly S, Grover NS, Hashmi H, Hashmi S, Hematti P, Hildebrandt GC, Hill JM Jr, Hossain NM, Ibrahim U, Johnson PC, Kharfan-Dabaja MA, Krem MM, Lekakis LJ, Maziarz RT, Murthy HS, Riedell PA, Salas MQ, Shouse G, Strouse C, Thakar MS, Turtle CJ, Woolfrey A, Wudhikarn K, Yared JA, Pasquini MC, Gowda L.: Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas. Blood Neoplasia 3: 100187, Nov 2025.
Rangarajan HG, Satwani P, Herr MM, Chen M, Martens MJ, Wudhikarn K, John S, Fabrizio VA, Hsieh EM, Kelkar AH, Doherty E, Marks DI, Ringden O, Friend BD, Kelly MS, Farhadfar N, Prestidge T, Hossain NM, Liu H, Hashmi S, Modi D, Winestone LE, El Boghdadly Z, Murthy HS, Perales MA, Chemaly RF, Dandoy CE, Hill JA, Huppler AR, Riches M, Auletta JJ.: Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR Analysis. Blood Adv 9: 5489-5500, Jul 2025.
Hossain NM, Ahn KW, Patel J, Lian Q, Abid B, Al Nughmush A, Bacher U, Bi X, Hashmi SK, Hilal T, Husnain M, Khimani F, Maziarz RT, Modi D, Ram R, Rizzieri D, Sica RA, Steinberg A, Vij R, Shadman M, Turtle C, Hamadani M, Herrera AF.: Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS. Br J Haematol Jul 2025.
Rowe M, Babushok D, Carroll M, Carulli A, Frey N, Gill S, Hexner E, Hirsh R, Hossain N, Lai C, Loren A, Luger S, Maillard I, McCurdy S, Matthews A, Martin ME, Paralkar VR, Perl A, Porter D, Pratz K, Stadtmauer E, Bruno XJ.: Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen. Eur J Haematol 114(4): 626-635, April 2025.
Khera N, Ailawadhi S, Brazauskas R, Patel J, Jacobs B, Ustun C, Ballen K, Abid MB, Diaz Perez MA, Al-Homsi AS, Hashem H, Hong S, Munker R, Schears RM, Lazarus HM, Ciurea S, Badawy SM, Savani BN, Wirk B, LeMaistre CF, Bhatt NS, Beitinjaneh A, Aljurf M, Sharma A, Cerny J, Knight JM, Kelkar AH, Yared JA, Kindwall-Keller T, Winestone LE, Steinberg A, Arnold SD, Seo S, Preussler JM, Hossain NM, Fingrut WB, Agrawal V, Hashmi S, Lehmann LE, Wood WA, Rangarajan HG, Saber W, Hahn T.: Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities. Blood Adv 8(13): 3497-3506, Jul 2024.
Wang TP, Ahn KW, Shadman M, Kaur M, Ahmed N, Bacher U, Cerny J, Chen A, Epperla N, Frigault M, Grover N, Haverkos B, Hill B, Hossain N, Iqbal M, Jain T, Krem MM, Maakaron J, Modi D, Alhaj Moustafa M, Riedell P, Savani B, Sica RA, Sureda A, Wudhikarn K, Herrera AF, Sauter C, Hamadani M, Jimenez Jimenez A.: Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis. Leukemia 38(7): 1564-1569, Jul 2024.
Shadman M, Ahn KW, Kaur M, Lekakis L, Beitinjaneh A, Iqbal M, Ahmed N, Hill B, Hossain NM, Riedell P, Gopal AK, Grover N, Frigault M, Brammer J, Ghosh N, Merryman R, Lazaryan A, Ram R, Hertzberg M, Savani B, Awan F, Khimani F, Ahmed S, Kenkre VP, Ulrickson M, Shah N, Kharfan-Dabaja MA, Herrera A, Sauter C, Hamadani M.: Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. Blood Cancer J 14(1): 108, Jul 2024.